EICHOR
● Recruiting
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma (HCC) · Sponsor: Shanghai Henlius Biotech
About this study
This is a multicenter, randomized, double-blind, parallel-controlled, phase I clinical study to evaluate the PK characteristics, safety, efficacy, and immunogenicity of HLX13 and US-sourced YERVOY® in patients with unresectable hepatocellular carcinoma who have not received prior systemic therapy.
This description comes directly from the study's public registry record.
Talk to the study team
Henlius · +86-021-33395800 · Xuhui_Hu@henlius.com
Always discuss trial participation with your own doctor first.
Locations (51)
| Oncology Physicians Network (OPN) - Los Alamitos /OPN Healthcare | Glendale, California, United States | Recruiting |
| Los Angeles Cancer Network | Glendale, California, United States | Not Yet Recruiting |
| Cancer Specialists of North Florida | Jacksonville, Florida, United States | Not Yet Recruiting |
| D&H National Research Centers, LLC | Margate, Florida, United States | Recruiting |
| Mid Florida Hematology and oncology Center | Orange City, Florida, United States | Recruiting |
| Florida Clinical Trials Group | Plantation, Florida, United States | Not Yet Recruiting |
| Florida Clinical Trials Group | Tamarac, Florida, United States | Not Yet Recruiting |
| HCA Research Institute, LLC | Brentwood, Tennessee, United States | Not Yet Recruiting |
| Oncology Consultants | Houston, Texas, United States | Recruiting |
| American Oncology Network Vista Oncology Division/Physician Partner Associate | Olympia, Washington, United States | Recruiting |
| Northwest Medical Specialties PLLC (NWMS) | Tacoma, Washington, United States | Recruiting |
| Cancer Hospital Chinese Academy of Medical Sciences | Beijing, China | Recruiting |
+ 39 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07176650